Invivyd Revenue

In the year 2025, Invivyd had annual revenue of $53.43M with 110.47% growth. Invivyd had revenue of $17.21M in the quarter ending December 31, 2025, with 24.51% growth.

Revenue (ttm)

$53.43M

Revenue Growth

+110.47%

P/S Ratio

7.78

Revenue / Employee

$437,918

Employees

122

Market Cap

340.78M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	53.43M	28.04M	110.47%
Dec 31, 2024	25.38M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Century Therapeutics	109.16M
Enanta Pharmaceuticals	69.21M
Verastem	49.59M
C4 Therapeutics	34.86M
X4 Pharmaceuticals	9.01M
PureTech Health	4.66M
vTv Therapeutics	17.00K

Revenue Rankings

IVVD News

4 hours ago - Invivyd Earnings Call Transcript: Q1 2026 - Transcripts
5 hours ago - Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
3 days ago - Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination - GlobeNewsWire
7 days ago - Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026 - GlobeNewsWire
9 days ago - Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
24 days ago - Invivyd annouces Chairman Elia to speak at POLITICO Health Care Summit - TheFly
24 days ago - Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit - GlobeNewsWire
5 weeks ago - Invivyd provides update on Phase 3 DECLARATION study of VYD2311 - TheFly

More News